Sleep Aids (Pharmacies) - ASEAN

  • ASEAN
  • Revenue in the Sleep Aids market is projected to reach US$119.30m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.24%, resulting in a market volume of US$161.50m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.17 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in ASEAN is witnessing a steady growth in recent years. Customer preferences for sleep aids have been shaped by various factors, leading to an increase in demand for these products. Additionally, there are several trends in the market that are contributing to its development.

Customer preferences:
Customers in ASEAN countries are increasingly seeking sleep aids to address their sleep-related issues. Factors such as hectic lifestyles, work stress, and the prevalence of digital devices have contributed to sleep disturbances among individuals. As a result, there is a growing demand for sleep aids that can help improve sleep quality and promote relaxation. Customers are looking for products that are safe, effective, and easily accessible through pharmacies.

Trends in the market:
One of the prominent trends in the Sleep Aids (Pharmacies) market in ASEAN is the increasing popularity of natural and herbal sleep aids. Customers are becoming more conscious of the ingredients used in sleep aids and are opting for products that contain natural and herbal extracts. This trend is driven by the growing preference for organic and natural products across various consumer segments. Another trend in the market is the availability of sleep aids in different forms. While traditional sleep aids such as pills and capsules continue to dominate the market, there is a rising demand for alternative formats such as gummies, teas, and sprays. This trend is driven by the desire for convenience and personalization, as customers seek sleep aids that suit their individual preferences and needs.

Local special circumstances:
In ASEAN countries, cultural practices and traditions may influence customer preferences for sleep aids. For example, countries like Thailand and Indonesia have a strong herbal medicine tradition, which may contribute to the popularity of natural sleep aids in these markets. Additionally, cultural beliefs and practices related to sleep and relaxation may shape customer preferences for certain types of sleep aids.

Underlying macroeconomic factors:
The growing middle class in ASEAN countries is a significant driver of the Sleep Aids (Pharmacies) market. As disposable incomes rise, individuals are willing to spend more on products that can improve their quality of life, including sleep aids. Additionally, increasing urbanization and changing lifestyles have led to higher stress levels and sleep disturbances, further fueling the demand for sleep aids. Furthermore, the expansion of the pharmacy retail sector in ASEAN countries has contributed to the growth of the Sleep Aids market. Pharmacies are widely accessible to the population, making it convenient for customers to purchase sleep aids. The presence of well-established pharmacy chains and the availability of a wide range of products have also played a role in driving the market forward. In conclusion, the Sleep Aids (Pharmacies) market in ASEAN is developing due to customer preferences for sleep aids that address their sleep-related issues. The market is characterized by trends such as the popularity of natural and herbal sleep aids and the availability of sleep aids in different forms. Local special circumstances, including cultural practices and traditions, may influence customer preferences in certain markets. Underlying macroeconomic factors such as the growing middle class and the expansion of the pharmacy retail sector also contribute to the market's development.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)